161 related articles for article (PubMed ID: 31692952)
1. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma.
Tanaka T; Kitamura H; Torigoe T; Hirohashi Y; Sato E; Masumori N; Sato N; Tsukamoto T
J Cancer Res Clin Oncol; 2011 May; 137(5):789-94. PubMed ID: 20676679
[TBL] [Abstract][Full Text] [Related]
3. Serum tissue factor as a biomarker for renal clear cell carcinoma.
Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
[TBL] [Abstract][Full Text] [Related]
4. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
5. The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.
Wu GY; Suo ST; Lu Q; Zhang J; Zhu WQ; Xu JR
PLoS One; 2015; 10(4):e0123431. PubMed ID: 25875306
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
7. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
8. Increased transforming growth factor beta1 plasma level in patients with renal cell carcinoma: a tumor-specific marker?
Wunderlich H; Steiner T; Kosmehl H; Junker U; Reinhold D; Reichelt O; Zermann DH; Schubert J
Urol Int; 1998 Aug; 60(4):205-7. PubMed ID: 9701731
[TBL] [Abstract][Full Text] [Related]
9. Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.
Kinouchi T; Uemura M; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Matsuzaki K; Nakata W; Yoshida T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
Cancer Sci; 2017 Dec; 108(12):2495-2502. PubMed ID: 28985012
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
11. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
[TBL] [Abstract][Full Text] [Related]
12. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.
Gayed BA; Gillen J; Christie A; Peña-Llopis S; Xie XJ; Yan J; Karam JA; Raj G; Sagalowsky AI; Lotan Y; Margulis V; Brugarolas J
BMC Urol; 2015 Apr; 15():24. PubMed ID: 25885592
[TBL] [Abstract][Full Text] [Related]
15. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
16. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
[TBL] [Abstract][Full Text] [Related]
17. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
Väänänen T; Kallio J; Vuolteenaho K; Ojala A; Luukkaala T; Hämäläinen M; Tammela T; Kellokumpu-Lehtinen PL; Moilanen E
Scand J Urol; 2017 Oct; 51(5):367-372. PubMed ID: 28644702
[TBL] [Abstract][Full Text] [Related]
18. SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.
Xu G; Xiang CQ; Lu Y; Wang WJ; Kang XN; Liao P; Ding Q; Zhang YF
Technol Cancer Res Treat; 2009 Jun; 8(3):225-30. PubMed ID: 19445540
[TBL] [Abstract][Full Text] [Related]
19. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.
Zheng H; Ji J; Zhao L; Chen M; Shi A; Pan L; Huang Y; Zhang H; Dong B; Gao H
Oncotarget; 2016 Sep; 7(37):59189-59198. PubMed ID: 27463020
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.
Han JH; Yoon YE; Kim SY; Cho YI; Rha KH; Choi YD; Han WK
Yonsei Med J; 2017 Mar; 58(2):388-394. PubMed ID: 28120570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
